David formally served as the Chief Medical Officer of Peptilogics and has approximately 20 years of clinical, academic, industry and research experience in infectious diseases and is well-versed in the design, execution of Phase I – III clinical trials for both antibacterials and antiviral agents. He also serves as an attending physician at the Department of Veterans Affairs and has had increasing responsibilities and leadership positions at Pfizer, ContraFect Corp, and Motif Bio. David earned his MD and PhD in Epidemiology from the University of Texas at School of Medicine and School of Public Health.